Longeveron (LGVN) Other Operating Expenses (2020 - 2024)

Longeveron's (LGVN) quarterly Other Operating Expenses came in at -$100000.0 in Q3 2024, down 281.82% year-on-year from $55000.0 in Q4 2023, and little changed quarter-over-quarter from -$100000.0 in Q2 2024.

Longeveron (LGVN) Other Operating Expenses (2020 - 2024) Analysis & Trends

Longeveron's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$100000.0 for Q3 2024.

  • On a quarterly basis, Other Operating Expenses fell 281.82% year-over-year to -$100000.0 in Q3 2024; TTM through Jun 2025 was -$100000.0, a 122.22% decrease from a year earlier, with the FY2025 full-year figure at -$97000.0, changed N/A from the prior year.
  • Other Operating Expenses held at -$100000.0 in Q3 2024 per LGVN's latest filing, from -$100000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $7.0 million in Q4 2021 and bottomed at -$1.4 million in Q2 2022.
  • The 5-year median for Other Operating Expenses is $288000.0 (2020), against an average of $913437.5.
  • Across the five-year window, Other Operating Expenses jumped 250.09% in 2021 and plunged 281.82% in 2024, its largest moves.
  • Year by year, Other Operating Expenses stood at $2.5 million in 2020, then soared by 174.66% to $7.0 million in 2021, then plunged by 95.91% to $285000.0 in 2022, then sank by 80.7% to $55000.0 in 2023, then plunged by 281.82% to -$100000.0 in 2024.
  • Per Business Quant, the three latest LGVN Other Operating Expenses figures stand at -$100000.0 (Q3 2024), -$100000.0 (Q2 2024), and $55000.0 (Q3 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00

Historic Data

Download Data
DateValue
Sep 30, 2024 -100,000.00
Jun 30, 2024 -100,000.00
Sep 30, 2023 55,000.00
Jun 30, 2023 80,000.00
Dec 31, 2022 285,000.00
Sep 30, 2022 -57,000.00
Jun 30, 2022 -1.40 Mn
Mar 31, 2022 287,000.00
Dec 31, 2021 6.96 Mn
Sep 30, 2021 2.05 Mn
Jun 30, 2021 1.96 Mn
Mar 31, 2021 550,000.00
Dec 31, 2020 2.53 Mn
Sep 30, 2020 585,000.00
Jun 30, 2020 642,000.00
Mar 31, 2020 289,000.00